Ikarian Capital LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 11:03 am Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 460,416 1.300% | -1,289,627 (-73.69%) | Filing |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 1,750,043 5.900% | -86,502 (-4.71%) | Filing |
| 2021-01-11 5:25 pm Purchase | 2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 1,836,545 6.200% | 1,836,545 (New Position) | Filing |